GPRO


Two Sides of Tesla Inc (TSLA) $1 Billion Funding, The Bearish Case for GoPro Inc (GPRO)

It has been a charged week for the tech-verse, with big announcements from Tesla Inc (NASDAQ:TSLA) and GoPro Inc (NASDAQ:GPRO) making waves through …

Legendary Value Investor Jean Marie Eveillard Adds Valeant Pharmaceuticals Intl Inc (VRX), GoPro Inc (GPRO), Withdraws Apple Inc. (AAPL)

Has famed value investor 76-year-old Jean Marie Eveillard missed the mark with ill-timed jumps and a lamentable retreat? When taking a glimpse at …

Thursday’s Market Insights: GoPro Inc (GPRO), Oracle Corporation (ORCL)

GoPro Inc (NASDAQ:GPRO) shares rose nearly 13% this morning, after the action cameras maker announced a restructuring plan and updated near-term financial targets. GoPro revealed that …

Snap Inc (SNAP) and GoPro Inc (GPRO) Signal Bearish Gamble for Investors

Analysts from Needham as well as from Goldman Sachs are indicating bearish forecasts on Snap Inc (NYSE:SNAP) and GoPro Inc (NASDAQ:GPRO), with shares …

Snap Inc (SNAP): Why You Should Not Buy The Time-Wasting Social Media Stock

Snapchat, a company that describes itself as a camera company yet makes no cameras, went public last week at a valuation of $24 …

Wedbush Unwilling To Recommend Glu Mobile Inc. (GLUU) and GoPro Inc (GPRO) Just Yet

Wedbush analyst Nick McKay is offering an earnings introspective from the sidelines on Glu Mobile Inc. (NASDAQ:GLUU) and GoPro Inc (NASDAQ:GPRO), ahead of Glu’s …

What’s Really Spooking Analysts About GoPro Inc (GPRO)

Analysts have been quick to sound the alarm on action camera developer GoPro Inc (NASDAQ:GPRO) with 3 sell ratings (Piper Jaffray, Raymond James, …

Analysts Highlight Buying Opportunity on Facebook Inc (FB), Remain Wary on GoPro Inc (GPRO)

Whereas Facebook Inc (NASDAQ:FB) is standing tall after strong revenue results in its fourth quarter, GoPro Inc (NASDAQ:GPRO) is quaking under the wake …

Friday’s Market Insights: Cerulean Pharma Inc (CERU), Pernix Therapeutics Holdings Inc (PTX) and GoPro Inc (GPRO)

Cerulean Pharma Inc (NASDAQ:CERU) are catapulting 60% after the cancer drug-maker has decided to confront recent missteps with the consideration of M&A possibilities. …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts